Company news
ValiRx PLC news in 2016
ValiRx PLC's news releases, calls and decks from 2016, newest first.
European Patent Granted for Lead Compound VAL201
December 8, 2016
Quarterly Update on Clinical Developments
November 29, 2016
Corporate Video re Clinical Status Q4, 2016
October 28, 2016
Patent Update
October 25, 2016
Update on Recent Presentations
October 13, 2016
CLN Conversion
October 5, 2016
ValiRx selected for The Parliamentary Review 2016
September 26, 2016
Placing, issue of warrants & Convertible Loan
September 2, 2016
Notification of New Zealand Patent Grant Allowance
July 28, 2016
Issue of Equity and Bracknor Facility Update
July 26, 2016
Result of GM
July 12, 2016
Sale of TRAC Technology Rights for EUR 0.8 million
July 7, 2016
Quarterly Update
June 7, 2016
Posting of Annual Report & Notice of AGM
May 26, 2016
Conversion of Loan Note, issue of warrant & equity
May 18, 2016
Notification of US Patent Grant for VAL401
April 29, 2016
ValiRx to exhibit at the UK Investor Show
April 22, 2016
Issue of Equity - conversion of loan note
April 19, 2016
ValiRx to exhibit and present at the AACR
March 31, 2016
Convertible Loan Facility of up to £4.0 million
March 21, 2016
ValiRx engages US investor relations firm
March 17, 2016
Placing to raise £0.5 million
February 17, 2016
Quarterly Update on Clinical Progress
February 9, 2016